Ad is loading...
BLRCX
Price
$11.47
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
CSFZX
Price
$54.36
Change
+$0.14 (+0.26%)
Updated
Nov 15 closing price
Ad is loading...

BLRCX vs CSFZX

Header iconBLRCX vs CSFZX Comparison
Open Charts BLRCX vs CSFZXBanner chart's image
Brookfield Global Listed Real Estate C
Price$11.47
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Cohen & Steers Global Realty Z
Price$54.36
Change+$0.14 (+0.26%)
VolumeN/A
CapitalizationN/A
BLRCX vs CSFZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BLRCX vs. CSFZX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRCX is a Buy and CSFZX is a Buy.

FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 1.91B vs. BLRCX (170M). CSFZX pays higher dividends than BLRCX: CSFZX (2.91) vs BLRCX (1.60). BLRCX was incepted earlier than CSFZX: BLRCX (13 years) vs CSFZX (10 years). BLRCX is a more actively managed with annual turnover of: 91.00 vs. CSFZX (52.00). CSFZX has a lower initial minimum investment than BLRCX: CSFZX (0) vs BLRCX (1000). CSFZX annual gain was more profitable for investors over the last year : 17.59 vs. BLRCX (15.52). CSFZX return over 5 years is better than : 7.33 vs. BLRCX (-6.53).
BLRCXCSFZXBLRCX / CSFZX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years10 years-
Gain YTD4.1616.10968%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets170M1.91B9%
Annual Yield % from dividends1.602.9155%
Returns for 1 year15.5217.5988%
Returns for 3 years-14.47-9.56151%
Returns for 5 years-6.537.33-89%
Returns for 10 years7.4548.0116%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
IDAI0.19N/A
-0.63%
T Stamp
MGEE104.86-0.84
-0.79%
MGE Energy
LKQ38.20-0.49
-1.27%
LKQ Corp
ATOS1.28-0.09
-6.57%
Atossa Therapeutics